Although the regulatory mechanism of TRIM9 gene expression and its biological functions remain unclear, our preliminary results suggest that methylated TRIM9 may serve as a novel blood biomarker specific to breast cancer patients. The gene discussed is TRIM9; the disease is breast carcinoma.